1,573
Views
23
CrossRef citations to date
0
Altmetric
Clinical Study

Curcumin and dexmedetomidine prevents oxidative stress and renal injury in hind limb ischemia/reperfusion injury in a rat model

, , , , , , , & show all
Pages 693-698 | Received 02 Sep 2015, Accepted 18 Feb 2016, Published online: 16 Mar 2016

References

  • Akar H, Sarac A, Konuralp C, Yildiz L, Kolbakir F. Comparison of histopathologic effects of carnitine and ascorbic acid on reperfusion injury. Eur J Cardiothorac Surg. 2001;19:500–506.
  • Grace PA. Ischaemia-reperfusion injury. Br J Surg. 1994;81:637–647.
  • Sirmali R, Armağan A, Oånktem F, et al. Protective effects of erdosteine, vitamin E, and vitamin C on renal injury induced by the ischemia-reperfusion of the hind limbs in rats. Turk J Med Sci. 2015;45:33–37.
  • Garbaisz D, Turoålczi Z, Füloånp A, et al. Postconditioning can reduce long-term lung injury after lower limb ischemia-reperfusion. Magy Seb. 2013;66:146–154.
  • Chen LN, Yang XH, Nissen DH, et al. Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice. Shock. 2013;40:420–429.
  • Nacif-Coelho C, Correa-Saler C, Chang LL, Maze M. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.. Anesthesiology. 1994;81:1527–1534.
  • Yoshitomi O, Cho S, Hara T, et al. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs. Shock. 2012;38:92–97.
  • Engelhard K, Werner CE, EberspaÅNcher E, et al. The effect of the α2-agonist dexmedetomidine and the N-methyl-d-aspartate antagonist S (+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003;96:524–531.
  • Cakir M, Polat A, Tekin S, et al. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats. Ren Fail. 2015;37:704–708.
  • Dong X, Xing Q, Li Y, Han X, Sun L. Dexmedetomidine protects against ischemia reperfusion injury in rat skeletal muscle. J Surg Res. 2014;186:240–245.
  • Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: A histopathologic study. Ren Fail. 2009;31:70–74.
  • Kilic K, Hanci V, Selek S, et al. The effects of dexmedetomidine on mesenteric arterial occlusion-associated gut ischemia and reperfusion-induced gut and kidney injury in rabbits. J Surg Res. 2012;178:223–232.
  • Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014:186864.
  • Aydin MS, Caliskan A, Kocarslan A, et al. Intraperitoneal curcumin decreased lung, renal and heart injury in abdominal aorta ischemia/reperfusion model in rat. Int J Surg. 2014;12:601–605.
  • Sak ME, Soydinc HE, Sak S, et al. The protective effect of curcumin on ischemia reperfusion injury in rat ovary. Int J Surg. 2013;11:967–970.
  • Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, Rowlands BJ. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002;26:115–121.
  • Sompamit K, Kukongviriyapan U, Nakmareong S, Pannangpetch P, Kukongviriyapan V. Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-induced endotoxaemia in mice. Eur J Pharmacol. 2009;616:192–199.
  • Avci G, Kadioglu H, Sehirli AO, et al. Curcumin protects against ischemia/reperfusion injury in rat skeletal muscle. J Surg Res. 2012;172:39–46.
  • Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153.
  • Solez K, Morel-Maroger L, Sraer JD. The morphology of “acute tubular necrosis” in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine. 1979;58:362–376.
  • Erel O. A novel automated method to measure total antioxidant response against potent-free radical reactions. Clin Biochem. 2004;37:112–119.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–1111.
  • Padowitz RA. Tourniquet-induced neuromuscular injury. A recent review of rabbit and clinical experimets. Acta Orthop Scand. 1991;245:1–33.
  • Estebe JP, Davies JM, Richebe P. The pneumatic tourniquet: Mechanical, ischaemia-reperfusion and systemic effects. Eur J Anaesthesiol. 2011;28:404–411.
  • Tugtepe H, Sener G, Biyikli NK, et al. The protective effect of oxytocin on renal ischemia/reperfusion injury in rats. Regul Pept. 2007;140:101–108.
  • Teruya R, Fagundes DJ, Oshima CT, et al. The effects of pentoxifylline into the kidneys of rats in a model of unilateral hindlimb ischemia/reperfusion injury. Acta Cir Bras. 2008;23:29–35.
  • Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev. 2009;14:141–153.
  • Rajagopalan R, Sridharana S, Menon VP. Hepatoprotective role of bis-demethoxy curcumin analog on the expression of matrix metalloproteinase induced by alcohol and polyunsaturated fatty acid in rats. Toxicol Mech Methods. 2010;20:252–259.
  • Reddy BV, Sivagama Sundari J, Balamurugan E, Menon VP. Antihyperlipidemic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione, a curcumin analog, on nicotine and streptozotocin treated rats. Mol Cell Biochem. 2010;335:249–254.
  • Kunchandy E, Rao A. Oxygen radical scavenging activity of curcumin. Int J Pharm. 1990;58:237–240.
  • Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the antiinflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41:40–59.
  • Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 1995;94:79–83.
  • Araujo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001;96:723–728.
  • Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. Adv Exp Med Biol. 2007;595:1–75.
  • Sreejayan, Rao MN. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol. 1994;46:1013–1016.
  • Reddy AC, Lokesh BR. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem. 1994;137:1–8.
  • Trujillo J, Chirino YI, Molina-Jijoåln E, Andeålrica-Romero AC, Tapia E, Pedraza-Chaverriål J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013;1:448–456.
  • Hammad FT, Al-Salam S, Lubbad L. Curcumin provides incomplete protection of the kidney in ischemia reperfusion injury. Physiol Res . 2012;61:503–511.
  • Bayrak O, Uz E, Bayrak R, et al. Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J Urol. 2008;26:285–291.
  • Lempiaåninen J, Finckenberg P, Mervaala EE, et al. Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury. Pharmacol Res Perspect. 2014;2:e00045.
  • Yagmurdur H, Ozcan N, Dokumaci F, Kilinc K, Yilmaz F, Basar H. Dexmedetomidine reduces the ischemia–reperfusion injury markers during upper extremity surgery with tourniquet. J Hand Surg Am. 2008;33:941–947.
  • Bostankolu E, Ayoglu H, Yurtlu S, et al. Dexmedetomidine did not reduce the effects of tourniquet-induced ischemia-reperfusion injury during general anesthesia. Kaohsiung J Med Sci. 2013;29:75–81.
  • Si YN, Bao HG, Xu L, et al. Dexmedetomidine protects against ischemia/reperfusion injury in rat kidney. Eur Rev Med Pharmacol Sci. 2014;18:1843–1851.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.